Francisco joined the FutureLife team in April 2023. With over 20 years of experience spanning multiple industries and geographies, including roles at AniCura (Veterinary Health - Europe), GrandVision (Optical retail – 43 countries), Nike (Wholesale / Retail – EMEA), and Banking (LATAM), Francisco excels in leading, mentoring, and inspiring teams to address complex business challenges with a focus on rapid improvement. He thrives in a culture characterized by integrity, inspiration, and curiosity. Francisco holds a Master's degree in Economics from the Universidad de Buenos Aires and an MBA from IAE Business School.

Jane joined FutureLife in September 2023 as Chief Growth Officer, bringing a wealth of expertise in marketing, pricing strategies, and business development. Jane's held various leadership roles at Debenhams. These roles enabled her to successfully demonstrate her ability to develop marketing talent, building high-performing teams, and deliver successful marketing campaigns across multiple media platforms. Her contributions have been recognised with many prestigious awards. These included the World Retail Award for Best Social Media Campaign, a Cannes Lion for an innovative digital Mother’s Day campaign, and most recently an award for a campaign which celebrated women’s health in mid-life. Throughout her career, she has shown a remarkable talent for brand positioning and precise consumer targeting. Collaborating closely with clinical leaders and using consumer insights has been a crucial part of her success.

Jarka joined FutureLife team as Chief Financial Officer in January 2024. Jarka has an extensive experience in financial management, business partnering, strategic planning and implementation with international reach within highly regulated industries. Jarka has served as Chief Financial Officer and a board member in several private equity portfolio as well as publicly listed companies. Until recently, and for almost 9 years, she was the Group CFO, member of the Executive Committee, and board member of the Fortuna Entertainment Group (FEG) where she played a critical role in the company’s step change value creation and business transformation across their 5 CEE markets. Prior to her role in FEG, Jaroslava served as CFO and board member in Prima banka Slovakia for 3,5 years, following CFO roles in CSOB Pojistovna and Ceska pojistovna. She also previously held a number of executive financial leadership roles at GE Capital where she worked for 12 years across the Czech Republic, Slovakia, the UK and Finland.

Ignacio joined FutureLife as Chief Transformation Officer in November 2023, bringing over 20 years of extensive experience in innovation and technology across Europe, the Americas, and the Middle East. Previously, as Managing Director at Seidor, Ignacio lead a comprehensive portfolio of innovation solutions across 39 countries. His leadership roles at NEORIS and CEMEX were instrumental in driving successful global digital transformation initiatives and establishing data-driven operations. His academic background includes a degree in Telecommunications Engineering, an MBA from IESE, and a degree in Philosophy.

In 2018, Dr. Štěpán Machač, PhD. joined FutureLife as the Chief Medical Officer. Previously, he held significant roles focusing on reproductive medicine. Graduating from Palacký University of Medicine in Olomouc, he also holds a PhD focusing on Inherited Thrombophilia related to severe OHSS. His career started at the Gynaecology and Obstetrics Clinic at Palacký University Olomouc from 1995 to 2003, where he began focusing on infertility treatment. Prior to his role at FutureLife, between 2006 and 2014, Dr. Machač was the lead IVF doctor for international patients at Reprofit International Clinic. Since 2014, he has overseen the IVF Clinic in Olomouc. Additionally, since 2020, Dr. Machač has been the Chairman of Section of Assisted Reproduction at the Czech Medical Society. He is also an author, writing ad co-writing over 30 lectures and 40 professional articles on assisted reproduction, ovarian hyperstimulation syndrome, and gamma donation.

Dr. Hans, Chief Medical Officer for WE, is an accomplished specialist with a passion for improving lives, through reproductive healthcare. He studied at Universidad Peruana Cayetano Heredia in Lima, Peru, where he worked with disadvantaged individuals for two years. He then continued his studies in Obstetrics and Gynaecology at Hospital Clinic de Barcelona in Spain. With nine years of experience at a leading fertility clinic in Barcelona, Dr. Hans has assisted infertile couples with medical and surgical treatments to start families. He is committed to providing personalised care and support, ensuring every patient receives the best treatment possible. Dr. Hans is committed to making a positive impact in reproductive medicine and helping individuals and couples achieve their dreams of starting a family.